Compare Mutual Funds

Pros
Lower expense ratio.

Lower expense ratio.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
2/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

8 Years 2 Months

13 Years 8 Months

Fund AUM

₹3091 Cr

₹8636 Cr

Min Investment
  1. SIP ₹99
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.44%

0.79%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

35

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.76%)
  2. Divi's Laboratories Ltd(8.23%)
  3. Glenmark Pharmaceuticals Ltd(7.12%)
  4. J.B. Chemicals & Pharmaceuticals Ltd(6.39%)
  5. Apollo Hospitals Enterprise Ltd(5.93%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(98.88%)
  2. Basic Materials(1.12%)

Health

(100%)

Equity %

99.96%

97.92%

Debt %

-

-

P/E

40.47

36.71

P/B

5.67

5.41

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

4.42%

4.62%

3-Month Return

15.68%

14.07%

6-Month Return

14.94%

9.88%

1-Year Return

15.94%

8.38%

3-Year Return

25.05%

21.81%

5-Year Return

15.94%

13.81%

Sharpe

1.13

1.03

Alpha

0.98

-0.47

Beta

0.97

0.9

Standard Deviation

16.89

15.79

Information Ratio

0.2

-0.65

Description

Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Vrijesh Kasera, Tanmay Mehta

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons